Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Malik Kahook to Angiogenesis Inhibitors

This is a "connection" page, showing publications Malik Kahook has written about Angiogenesis Inhibitors.

 
Connection Strength
 
 
 
3.568
 
  1. SooHoo JR, Seibold LK, Pantcheva MB, Kahook MY. Aflibercept for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2015 Dec; 43(9):803-7.
    View in: PubMed
    Score: 0.407
  2. SooHoo JR, Seibold LK, Kahook MY. The link between intravitreal antivascular endothelial growth factor injections and glaucoma. Curr Opin Ophthalmol. 2014 Mar; 25(2):127-33.
    View in: PubMed
    Score: 0.372
  3. Ammar DA, Mandava N, Kahook MY. The effects of aflibercept on the viability and metabolism of ocular cells in vitro. Retina. 2013 May; 33(5):1056-61.
    View in: PubMed
    Score: 0.351
  4. SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Semin Ophthalmol. 2013 May; 28(3):165-72.
    View in: PubMed
    Score: 0.351
  5. Horsley MB, Mandava N, Maycotte MA, Kahook MY. Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 2010 Oct; 150(4):558-561.e1.
    View in: PubMed
    Score: 0.293
  6. Kahook MY, Ammar DA. In vitro effects of antivascular endothelial growth factors on cultured human trabecular meshwork cells. J Glaucoma. 2010 Sep; 19(7):437-41.
    View in: PubMed
    Score: 0.292
  7. Good TJ, Kimura AE, Mandava N, Kahook MY. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol. 2011 Aug; 95(8):1111-4.
    View in: PubMed
    Score: 0.291
  8. Kahook MY, Liu L, Ruzycki P, Mandava N, Carpenter JF, Petrash JM, Ammar DA. High-molecular-weight aggregates in repackaged bevacizumab. Retina. 2010 Jun; 30(6):887-92.
    View in: PubMed
    Score: 0.287
  9. Horsley MB, Kahook MY. Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol. 2010 Mar; 21(2):112-7.
    View in: PubMed
    Score: 0.282
  10. Kahook MY, Kimura AE, Wong LJ, Ammar DA, Maycotte MA, Mandava N. Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging. 2009 May-Jun; 40(3):293-5.
    View in: PubMed
    Score: 0.266
  11. Torres JA, Fischer NA, Seibold LK, Pantcheva MB, Kahook MY, SooHoo JR. A Survey of Patient Perceptions and Preferences for Glaucoma Treatment with Intravitreal Injections. Ophthalmol Glaucoma. 2018 Jul - Aug; 1(1):61-65.
    View in: PubMed
    Score: 0.126
  12. Liu L, Ammar DA, Ross LA, Mandava N, Kahook MY, Carpenter JF. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling. Invest Ophthalmol Vis Sci. 2011 Feb; 52(2):1023-34.
    View in: PubMed
    Score: 0.075
  13. Kahook MY. Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol. 2010 Sep; 150(3):399-403.e1.
    View in: PubMed
    Score: 0.072
  14. Hazin R, Freeman PD, Kahook MY. Age-related macular degeneration: a guide for the primary care physician. J Natl Med Assoc. 2009 Feb; 101(2):134-8.
    View in: PubMed
    Score: 0.065
  15. Levin AM, Chaya CJ, Kahook MY, Wirostko BM. Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations. J Glaucoma. 2021 12 01; 30(12):1019-1026.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)